MAPKAPK2 Recombinant Monoclonal Antibody

說明書

中文名稱：

MAPKAPK2重組抗體
貨號(hào)：

CSB-RA990134A0HU
規(guī)格：

￥1320
圖片：
Western Blot
Positive WB detected in: Hela whole cell lysate, HEK293 whole cell lysate, THP-1 whole cell lysate
All lanes: MAPKAPK2 antibody at 1:1000
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 46, 43 kDa
Observed band size: 49 kDa

IHC image of CSB-RA990134A0HU diluted at 1:100 and staining in paraffin-embedded human breast cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4℃ overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.

IHC image of CSB-RA990134A0HU diluted at 1:100 and staining in paraffin-embedded human heart tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4℃ overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品描述：

MAPKAPK2 Recombinant Monoclonal Antibody（CSB-RA990134A0HU）靶向絲裂原活化蛋白激酶激活蛋白激酶2（MAPKAPK2），該蛋白是p38 MAPK信號(hào)通路下游的關(guān)鍵效應(yīng)分子，參與調(diào)控炎癥反應(yīng)、細(xì)胞應(yīng)激及細(xì)胞周期進(jìn)程等多種生物學(xué)過程。本抗體通過重組技術(shù)制備，具有高親和力和特異性，經(jīng)ELISA、Western Blot（WB）及免疫組化（IHC）等多種方法驗(yàn)證，可在WB實(shí)驗(yàn)中于推薦稀釋度1:500-1:5000范圍內(nèi)清晰檢測(cè)目標(biāo)蛋白，并在IHC應(yīng)用中（推薦稀釋度1:50-1:200）呈現(xiàn)明確的組織定位信號(hào)。其單克隆特性確保批次間高度一致性，適用于研究MAPKAPK2在炎癥相關(guān)疾病模型、腫瘤微環(huán)境調(diào)控或神經(jīng)退行性疾病中的表達(dá)變化及功能機(jī)制，為探索p38 MAPK通路在細(xì)胞應(yīng)激反應(yīng)、免疫調(diào)節(jié)等領(lǐng)域的分子機(jī)制提供可靠工具。該產(chǎn)品嚴(yán)格適用于體外實(shí)驗(yàn)研究，不涉及其他用途。
Uniprot No.：

P49137
基因名：

MAPKAPK2
別名：

MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1), MAPKAPK2
反應(yīng)種屬：

Human
免疫原：

A synthesized peptide derived from human MAPKAP Kinase 2
免疫原種屬：

Homo sapiens (Human)
標(biāo)記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

Rabbit IgG
純化方式：

Affinity-chromatography
克隆號(hào)：

4H8
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, WB, IHC

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:5000
IHC	1:50-1:200

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3.
基因功能參考文獻(xiàn)：
1. Study found an elevated expression level of MK2 in serum specimens of patients with spinal cord injury. MiR-137 targets MK2 and inhibits its mediated inflammatory response and apoptosis after spinal cord injury. PMID: 29125882
2. The novel MK2 substrates have emerged in the DNA damage response, autophagy, and obesity, making MK2 a multifunctional kinase at the crossroads of stress response and cell death. PMID: 29275999
3. According to the information mentioned above, we now report the design and synthesis of some series of new urea derivatives that were then evaluated for their inhibitory activities against MAPKAPK2, TNF-a, and p38a PMID: 27223276
4. MK2 post-transcriptionally regulates TNF-alpha-induced ICAM-1 expression by altering the cytoplasmic localization of HuR in human lung microvascular endothelial cells. PMID: 27215284
5. MK2 overexpression is associated with primary liver tumors. PMID: 26169728
6. mTOR controls the senescence-associated secretory phenotype by differentially regulating the translation of the MK2 (also known as MAPKAPK2). PMID: 26280535
7. analysis of signaling cooperation between p38-MAPK/MAPKAP-2/Hsp27 and intracellular calcium release in AA-induced HBEC apoptosis PMID: 24802256
8. Low pMK2 expression was found to correlate significantly with overall survival after induction plus chemoradiation therapy in head and neck squamous cell carcinoma patients. PMID: 25019640
9. The protein expression of both HMGB1 and MAPKAPK2 were increased in KLM1-R cells. PMID: 26124331
10. Data indicate the binding mode and molecular mechanism of action of MAPK-activated protein kinase-2 (MK2) and inhibitors. PMID: 25255283
11. Treatment with MK2 or p38 inhibitors blocked human papillomavirus genome amplification, identifying the p38/MK2 pathway as a key regulator of the human papillomavirus life cycle. PMID: 25410865
12. a key role of MK2 and FasR in the regulation and limitation of the immune response in the CNS PMID: 24964076
13. IscU is a new substrate of MK2 both in Drosophila cells and in human cells PMID: 25204651
14. MK2 mediates gemcitabine efficacy in pancreatic cancer cells that respond to the drug, suggesting that the p38/MK2 pathway represents a determinant of the efficacy by that gemcitabine counteracts pancreatic cancer. PMID: 24556918
15. MK2 plays a critical role in the development of apoptosis. PMID: 24304496
16. ATM and MAPKAP kinase 2 mediate radiation sensitivity in pancreatic cancer cells via phosphorylation of TRIM29. PMID: 24469230
17. the functional copy number variation 30450 in the MAPKAPK2 promoter elevates the nasopharyngeal carcinoma risk with a modulation by EBV infection PMID: 24056810
18. These data suggest that MK2 is a key downstream effector of p38 that can modulate pemphigus vulgaris autoantibody pathogenicity. PMID: 23657501
19. MK2 activity was required for damage response, accumulation of ssDNA, and decreased survival when cells were treated with the nucleoside analogue gemcitabine or when the checkpoint kinase Chk1 was antagonized. PMID: 24082115
20. MK2 gene rs45514798 polymorphisms may be associated with HDL-C in Uygur men younger than 50 years old from Hetian area of Xinjiang. PMID: 23744329
21. Kaposin B significantly contributes to the chronic inflammatory environment by unique activation of the proto-oncogene STAT3, coupled with MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28. PMID: 23740979
22. activation of PP2A or inactivation of the p38MAPK-MAPKAPK2-Hsp27 has a role in survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity PMID: 23185379
23. This study showed that MK2 kinase is activated by TcdA and TcdB and regulates the expression of proinflammatory cytokines. PMID: 23264053
24. Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells. PMID: 22983351
25. A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer PMID: 22883146
26. Data show that MAPKAP kinase 2 overexpression is associated with expression of p38 MAP kinase and ETV1 in gastrointestinal stromal tumors (GIST). PMID: 22351694
27. analysis of inhibition of human MK2 PMID: 22119462
28. TLR3 induces signaling mechanisms involving TRIF, p38 MAPK and MK2 to enhance stabilization of IFN-beta mRNA contributing to enhanced IFN-beta levels during pathogen infections. PMID: 22200507
29. MK2 SUMOylation is a new mechanism for regulating actin filament dynamics in ECs. PMID: 21131586
30. Demonstrate a critical role for the MK2 pathway in the posttranscriptional regulation of gene expression as part of the DNA damage response in cancer cells. PMID: 20932473
31. MK2 phosphorylation reduces the ability of TTP to promote deadenylation by inhibiting the recruitment of CAF1 deadenylase in a mechanism that does not involve sequestration of TTP by 14-3-3. PMID: 20595389
32. Tumor necrosis factor (TNF)-alpha protein, but not messenger RNA production, is markedly impaired by MK2 deficiency of transgenic mice. PMID: 20375303
33. From a siRNA screen of the human kinome adapted to a high-throughput format, we found that knock-down of the MAPK-activated protein kinase 2 (MK2), a downstream target of the p38 MAPK, protected against Shiga toxicity. PMID: 19951368
34. miR-34c is a critical regulator of c-Myc expression following DNA damage acting downstream of p38 MAPK/MK2, and miR-34c serves to remove c-Myc to prevent inappropriate replication which may otherwise lead to genomic instability. PMID: 20212154
35. Data provide evidence that p38 Map kinase pathway is activated leading to increased upregulation of mixed lineage kinase 3, MKK3/6, MSK1, and Mapkapk2, upon treatment of BCR/ABL expressing cells with dasatinib PMID: 19672773
36. Findings implicate p38 MAPK and MAPKAPK2 in mediating bladder cancer invasion via regulation of MMP-2 and MMP-9 at the level of mRNA stability. PMID: 20068172
37. MK2 signaling has a minor role in skin inflammation [commentary] PMID: 20081887
38. Examination of the kinetic mechanism PMID: 12147348
39. structure suggests a bifunctional switch that couples kinase activation with nuclear export PMID: 12171911
40. role in pathway that promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells PMID: 12377770
41. MAPKAPK-2 and ERKs activate 5-lipoxygenase PMID: 12751751
42. crystal structures of a catalytically active C-terminal deletion form of human MAP KAP kinase 2, residues 41-364, in complex with staurosporine at 2.7 A and with ADP at 3.2 A PMID: 12791252
43. MK2 is activated with p66(ShcA) co-expression and p66(ShcA) is an in vitro substrate for MK2, further demonstrating their association and suggesting a biological role for p66(Shc) in MK2 activation PMID: 15094067
44. BAG2 was directly phosphorylated at serine 20 in vitro by MAPKAPK2 and MAPKAP2 is also required for phosphorylation of BAG2 in vivo. PMID: 15271996
45. The 30-amino acid docking domain peptide of MAPKAPK2 isoform a (MK2a) is required for the formation of a tight, functional p38alpha-MK2a signaling complex. PMID: 15287722
46. MAPKAP kinase-2 is directly responsible for Cdc25B/C phosphorylation and 14-3-3 binding in vitro and in response to UV-induced DNA damage. PMID: 15629715
47. Kaposin B reverses the instability of cytokine trnscripts by binding to and activating mitogen-activated protein kinase-associated protein kinase 2, a target of the p38 mitogen-activated protein kinase signaling pathway and inhibitor of ARE-mRNA decay PMID: 15692053
48. HSF1 phosphorylation by MAPK-activated protein kinase 2 on serine 121, inhibits transcriptional activity and promotes HSP90 binding PMID: 16278218
49. Both MAPKAPK2 and HSP27 are necessary for TGFbeta-mediated increases in MMP-2 and cell invasion in human prostate cancer. PMID: 16407830
50. Increased activation of MAPKAP2 is responsible for elevated and posttranscriptionally regulated TNF-alpha protein expression in psoriatic skin. PMID: 16424170
顯示更多

收起更多
亞細(xì)胞定位：

Cytoplasm. Nucleus. Note=Phosphorylation and subsequent activation releases the autoinhibitory helix, resulting in the export from the nucleus into the cytoplasm.
蛋白家族：

Protein kinase superfamily, CAMK Ser/Thr protein kinase family
組織特異性：

Expressed in all tissues examined.
數(shù)據(jù)庫鏈接：

HGNC: 6887

OMIM: 602006

KEGG: hsa:9261

STRING: 9606.ENSP00000356070

UniGene: Hs.643566

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human